<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03146793</url>
  </required_header>
  <id_info>
    <org_study_id>Centre Hospitalier St Esprit</org_study_id>
    <nct_id>NCT03146793</nct_id>
  </id_info>
  <brief_title>The Early Administration of Sodium Thiosulfate Should Help to Reduce the Mortality of Dialysis Patients With Calciphylaxis, From a National Cohort</brief_title>
  <official_title>National Follow-up of Dialysis Patients With Sodium Thiosufate-treated Calciphylaxis Under Temporary Use Authorization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier St Esprit</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier St Esprit</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The national drug safety agency authorizes nominatively the use of sodium thiosulfate in
      dialysis patients with calciphylaxis. To date, it is the largest global cohort (more 600
      patients from 2012 to 2016). We wanted to study retrospectively the fate of these patients at
      6 months including mortality. Early use improves effectiveness.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Anticipated">February 28, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>time factor on mortality</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Calciphylaxis</condition>
  <condition>Renal Insufficiency, Chronic</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Thiosulfate</intervention_name>
    <description>25g intravenously 3 times per week</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Dialysis patients with calciphylaxis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All dialysis patients with calciphylaxis in France who have obtained a temporary use
             authorization for sodium thiosulfate by National Agency for the Safety of Medicines

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Albert TRINH-DUC, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier St EPSRIT AGEN FRANCE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Albert TRINH-DUC, MD</last_name>
    <phone>0033675743871</phone>
    <email>albert.trinh-duc@wanadoo.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Isabelle MOUSNIER, MD</last_name>
    <phone>0033660190002</phone>
    <email>dr_eaza@yahoo.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre Hospitalier St ESPRIT</name>
      <address>
        <city>Agen</city>
        <zip>47000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Albert TRINH-DUC, MD</last_name>
      <phone>0033675743871</phone>
      <email>albert.trinh-duc@wanadoo.fr</email>
    </contact>
    <contact_backup>
      <last_name>Isabelle MOUSNIER, MD</last_name>
      <phone>0033660190002</phone>
      <email>dr_eaza@yahoo.fr</email>
    </contact_backup>
    <investigator>
      <last_name>David LARMET BURGEOT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Weenig RH, Sewell LD, Davis MD, McCarthy JT, Pittelkow MR. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007 Apr;56(4):569-79. Epub 2006 Dec 1.</citation>
    <PMID>17141359</PMID>
  </reference>
  <reference>
    <citation>Perceau G. [Uraemic and non-uraemic calcific arteriopathy: The need for rapid diagnosis and therapy]. Ann Dermatol Venereol. 2015 Aug-Sep;142(8-9):506-12. doi: 10.1016/j.annder.2015.06.009. Epub 2015 Aug 5. French.</citation>
    <PMID>26253008</PMID>
  </reference>
  <reference>
    <citation>Nigwekar SU, Brunelli SM, Meade D, Wang W, Hymes J, Lacson E Jr. Sodium thiosulfate therapy for calcific uremic arteriolopathy. Clin J Am Soc Nephrol. 2013 Jul;8(7):1162-70. doi: 10.2215/CJN.09880912. Epub 2013 Mar 21.</citation>
    <PMID>23520041</PMID>
  </reference>
  <reference>
    <citation>Brandenburg VM, Kramann R, Rothe H, Kaesler N, Korbiel J, Specht P, Schmitz S, Kr√ºger T, Floege J, Ketteler M. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry. Nephrol Dial Transplant. 2017 Jan 1;32(1):126-132. doi: 10.1093/ndt/gfv438.</citation>
    <PMID>26908770</PMID>
  </reference>
  <reference>
    <citation>Sood AR, Wazny LD, Raymond CB, Leung K, Komenda P, Reslerova M, Verrelli M, Rigatto C, Sood MM. Sodium thiosulfate-based treatment in calcific uremic arteriolopathy: a consecutive case series. Clin Nephrol. 2011 Jan;75(1):8-15.</citation>
    <PMID>21176746</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2017</study_first_submitted>
  <study_first_submitted_qc>May 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 10, 2017</study_first_posted>
  <last_update_submitted>May 8, 2017</last_update_submitted>
  <last_update_submitted_qc>May 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier St Esprit</investigator_affiliation>
    <investigator_full_name>Albert TRINH-DUC</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Calciphylaxis/complications</keyword>
  <keyword>Kidney Failure, Chronic/complications</keyword>
  <keyword>Renal Dialysis</keyword>
  <keyword>Thiosulfates/therapeutic use</keyword>
  <keyword>Time Factors</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Calciphylaxis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sodium thiosulfate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

